AAAAAA
Results:
1-16
|
Results: 16
Authors:
Takada, K
Illei, GG
Boumpas, DT
Citation: K. Takada et al., Cyclophosphamide for the treatment of systemic lupus erythematosus, LUPUS, 10(3), 2001, pp. 154-161
Authors:
Boumpas, DT
Citation: Dt. Boumpas, Lupus nephritis, NEPH DIAL T, 16, 2001, pp. 55-57
Authors:
Kuo, GM
Boumpas, DT
Illei, GG
Yarboro, C
Pucino, F
Burstein, AH
Citation: Gm. Kuo et al., Fludarabine pharmacokinetics after subcutaneous and intravenous administration in patients with lupus nephritis, PHARMACOTHE, 21(5), 2001, pp. 528-533
Authors:
McInnes, IB
Illei, GG
Danning, CL
Yarboro, CH
Crane, M
Kuroiwa, T
Schlimgen, R
Lee, E
Foster, B
Flemming, D
Prussin, C
Fleisher, TA
Boumpas, DT
Citation: Ib. Mcinnes et al., IL-10 improves skin disease and modulates endothelial activation and leukocyte effector function in patients with psoriatic arthritis, J IMMUNOL, 167(7), 2001, pp. 4075-4082
Authors:
Papadaki, HA
Boumpas, DT
Gibson, FM
Jayne, DR
Axford, JS
Gordon-Smith, EC
Marsh, JCW
Eliopoulos, GD
Citation: Ha. Papadaki et al., Increased apoptosis of bone marrow CD34(+) cells and impaired function of bone marrow stromal cells in patients with systemic lupus erythematosus, BR J HAEM, 115(1), 2001, pp. 167-174
Authors:
Illei, GG
Austin, HA
Crane, M
Collins, L
Gourley, MF
Yarboro, CH
Vaughan, EM
Kuroiwa, T
Danning, CL
Steinberg, AD
Klippel, JH
Balow, JE
Boumpas, DT
Citation: Gg. Illei et al., Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis, ANN INT MED, 135(4), 2001, pp. 248-257
Authors:
Paliogianni, F
Boumpas, DT
Citation: F. Paliogianni et Dt. Boumpas, Molecular and cellular aspects of cytokine regulation by glucocorticoids, MIL DRUG TH, 2001, pp. 81-101
Authors:
Balow, JE
Boumpas, DT
Austin, HA
Citation: Je. Balow et al., New prospects for treatment of lupus nephritis, SEM NEPHROL, 20(1), 2000, pp. 32-39
Authors:
Kuroiwa, T
Schlimgen, R
Illei, GG
McInnes, IB
Boumpas, DT
Citation: T. Kuroiwa et al., Distinct T cell/renal tubular epithelial cell interactions define differential chemokine production: Implications for tubulointerstitial injury in chronic glomerulonephritides, J IMMUNOL, 164(6), 2000, pp. 3323-3329
Authors:
Danning, CL
Illei, GG
Hitchon, C
Greer, MR
Boumpas, DT
McInnes, IB
Citation: Cl. Danning et al., Macrophage-derived cytokine and nuclear factor kappa B p65 expression in synovial membrane and skin of patients with psoriatic arthritis, ARTH RHEUM, 43(6), 2000, pp. 1244-1256
Authors:
Davis, JC
Manzi, S
Yarboro, C
Rairie, J
Mcinnes, I
Averthelyi, D
Sinicropi, D
Hale, VG
Balow, J
Austin, H
Boumpas, DT
Klippel, JH
Citation: Jc. Davis et al., Recombinant human Dnase I (rhDNase) in patients with lupus nephritis, LUPUS, 8(1), 1999, pp. 68-76
Authors:
Boumpas, DT
Tassiulas, IO
Fleisher, TA
Vaughan, E
Piscitelli, S
Kim, Y
Pucino, F
Balow, JE
Austin, HA
Citation: Dt. Boumpas et al., A pilot study of low-dose fludarabine in membranous nephropathy refractoryto therapy, CLIN NEPHR, 52(2), 1999, pp. 67-75
Authors:
Tassiulas, I
Duncan, SR
Centola, M
Theofilopoulos, AN
Boumpas, DT
Citation: I. Tassiulas et al., Clonal characteristics of T cell infiltrates in skin and synovium of patients with psoriatic arthritis, HUMAN IMMUN, 60(6), 1999, pp. 479-491
Authors:
Kuroiwa, T
Lee, EG
Danning, CL
Illei, GG
McInnes, IB
Boumpas, DT
Citation: T. Kuroiwa et al., CD40 ligand-activated human monocytes amplify glomerular inflammatory responses through soluble and cell-to-cell contact-dependent mechanisms, J IMMUNOL, 163(4), 1999, pp. 2168-2175
Authors:
Lu, LJ
Kaliyaperumal, A
Boumpas, DT
Datta, SK
Citation: Lj. Lu et al., Major peptide autoepitopes for nucleosome-specific T cells of human lupus, J CLIN INV, 104(3), 1999, pp. 345-355
Authors:
Boumpas, DT
Balow, JE
Citation: Dt. Boumpas et Je. Balow, Outcome criteria for lupus nephritis trials: A critical overview, LUPUS, 7(9), 1998, pp. 622-629
Risultati:
1-16
|